SpaceX accelerates IPO timeline, targets June 12 Nasdaq listing
SpaceX has accelerated its IPO timeline and is targeting a June 12 listing on Nasdaq, according to sources familiar with the matter.
SpaceX has accelerated its IPO timeline and is targeting a June 12 listing on Nasdaq, according to sources familiar with the matter.
Apollo Funds announced the completion of its $2.04 billion acquisition of Bodycote, a global leader in thermal processing services for the aerospace and industrial sectors.
Cerebras increased its IPO price range as demand from institutional investors exceeded available shares, signaling strong appetite for AI chip infrastructure plays.
Seaport Therapeutics, a neuropsychiatric therapeutics company, set terms for its $201 million IPO with pricing scheduled for this week.
Canada Pension Plan Investment Board committed more than $22 billion to private markets in fiscal 2026, signaling sustained appetite for illiquid asset classes despite public market volatility.
Recent 13F disclosures reveal significant shifts in activist and hedge fund positioning: Bill Ackman built a substantial Microsoft stake during Q1, Leopold Aschenbrenner's fund acquired Bloom Energy before its 176% surge, while Elliott Management exited two tech positions and increased its Hewlett Packard Enterprise holding.
Terra Quantum and Axiom Intelligence Acquisition Corp 1 announced a definitive business combination agreement at a $3.5 billion equity valuation, marking one of the larger quantum computing valuations in a SPAC context.